327 related articles for article (PubMed ID: 23660242)
1. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients.
van de Glind G; van den Brink W; Koeter MW; Carpentier PJ; van Emmerik-van Oortmerssen K; Kaye S; Skutle A; Bu ET; Franck J; Konstenius M; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitány-Fövény M; Fatséas M; Auriacombe M; Schillinger A; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Barta C; Schoevers RA; ; Levin FR
Drug Alcohol Depend; 2013 Oct; 132(3):587-96. PubMed ID: 23660242
[TBL] [Abstract][Full Text] [Related]
2. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.
van de Glind G; Van Emmerik-van Oortmerssen K; Carpentier PJ; Levin FR; Koeter MW; Barta C; Kaye S; Skutle A; Franck J; Konstenius M; Bu ET; Moggi F; Dom G; Demetrovics Z; Fatséas M; Schillinger A; Kapitány-Fövény M; Verspreet S; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Allsop S; Carruthers S; Schoevers RA; ; van den Brink W
Int J Methods Psychiatr Res; 2013 Sep; 22(3):232-44. PubMed ID: 24022983
[TBL] [Abstract][Full Text] [Related]
3. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
van Emmerik-van Oortmerssen K; van de Glind G; Koeter MW; Allsop S; Auriacombe M; Barta C; Bu ET; Burren Y; Carpentier PJ; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitány-Fövény M; Kaye S; Konstenius M; Levin FR; Moggi F; Møller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; ; van den Brink W; Schoevers RA
Addiction; 2014 Feb; 109(2):262-72. PubMed ID: 24118292
[TBL] [Abstract][Full Text] [Related]
5. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.
van de Glind G; Konstenius M; Koeter MWJ; van Emmerik-van Oortmerssen K; Carpentier PJ; Kaye S; Degenhardt L; Skutle A; Franck J; Bu ET; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitány-Fövény M; Fatséas M; Auriacombe M; Schillinger A; Møller M; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Schoevers RA; Wallhed S; Barta C; Alleman P; ; Levin FR; van den Brink W
Drug Alcohol Depend; 2014 Jan; 134():158-166. PubMed ID: 24156882
[TBL] [Abstract][Full Text] [Related]
6. Screening for attention-deficit/hyperactivity disorder in borderline personality disorder.
Weibel S; Nicastro R; Prada P; Cole P; Rüfenacht E; Pham E; Dayer A; Perroud N
J Affect Disord; 2018 Jan; 226():85-91. PubMed ID: 28964997
[TBL] [Abstract][Full Text] [Related]
7. The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders.
Dakwar E; Mahony A; Pavlicova M; Glass A; Brooks D; Mariani JJ; Grabowski J; Levin FR
J Clin Psychiatry; 2012 Nov; 73(11):e1372-8. PubMed ID: 23218166
[TBL] [Abstract][Full Text] [Related]
8. Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: Underreporting of ADHD symptoms in self-report scales.
Luderer M; Kaplan-Wickel N; Richter A; Reinhard I; Kiefer F; Weber T
Drug Alcohol Depend; 2019 Feb; 195():52-58. PubMed ID: 30583265
[TBL] [Abstract][Full Text] [Related]
9. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5.
Ustun B; Adler LA; Rudin C; Faraone SV; Spencer TJ; Berglund P; Gruber MJ; Kessler RC
JAMA Psychiatry; 2017 May; 74(5):520-527. PubMed ID: 28384801
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Utility of ASRS-v1.1 for Identifying ADHD in Alcoholics Using PRISM as the Reference Standard.
Reyes MM; Schneekloth TD; Hitschfeld MJ; Geske JR; Atkinson DL; Karpyak VM
J Atten Disord; 2019 Aug; 23(10):1119-1125. PubMed ID: 27138328
[No Abstract] [Full Text] [Related]
11. Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders.
Daigre Blanco C; Ramos-Quiroga JA; Valero S; Bosch R; Roncero C; Gonzalvo B; Nogueira M
Actas Esp Psiquiatr; 2009; 37(6):299-305. PubMed ID: 20066581
[TBL] [Abstract][Full Text] [Related]
12. [ASRS v.1.1., a tool for attention-deficit/hyperactivity disorder screening in adults treated for addictive behaviors: psychometric properties and estimated prevalence].
Pedrero Pérez EJ; Puerta García C
Adicciones; 2007; 19(4):393-407. PubMed ID: 18173102
[TBL] [Abstract][Full Text] [Related]
13. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder.
Coetzee C; Truter I; Meyer A
Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1271-1280. PubMed ID: 33040639
[TBL] [Abstract][Full Text] [Related]
15. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population.
Kessler RC; Adler L; Ames M; Demler O; Faraone S; Hiripi E; Howes MJ; Jin R; Secnik K; Spencer T; Ustun TB; Walters EE
Psychol Med; 2005 Feb; 35(2):245-56. PubMed ID: 15841682
[TBL] [Abstract][Full Text] [Related]
16. A Cross-sectional Cohort Study of Prevalence, Co-Morbidities, and Correlates of Attention-deficit Hyperactivity Disorder among Adult Patients Admitted to the Li Ka Shing Psychiatric Outpatient Clinic, Hong Kong.
Leung VM; Chan LF
East Asian Arch Psychiatry; 2017 Jun; 27(2):63-70. PubMed ID: 28652499
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the Japanese version of the Adult Attention-deficit hyperactivity disorder (ADHD) Self-Report Scale (ASRS-J) and its short scale in accordance with DSM-5 diagnostic criteria.
Takeda T; Tsuji Y; Kurita H
Res Dev Disabil; 2017 Apr; 63():59-66. PubMed ID: 28260624
[TBL] [Abstract][Full Text] [Related]
18. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
[TBL] [Abstract][Full Text] [Related]
19. The Validity of the World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition in Adolescence.
Somma A; Adler LA; Gialdi G; Arteconi M; Cotilli E; Fossati A
J Child Adolesc Psychopharmacol; 2021 Nov; 31(9):631-638. PubMed ID: 34166067
[No Abstract] [Full Text] [Related]
20. Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study.
Vold JH; Halmøy A; Chalabianloo F; Pierron MC; Løberg EM; Johansson KA; Fadnes LT
BMC Psychiatry; 2023 Jun; 23(1):479. PubMed ID: 37386438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
